PDA was founded in 1946 as the Parenteral Drug Association by a small group of pharmaceutical manufacturers who recognized the need for an organization to disseminate technical information within the industry. Today, coordinated through its headquarters and manufacturing training facility in Bethesda, Maryland, and Europe office in Berlin, Germany, PDA volunteers worldwide carry out its mission of promoting the exchange of rapidly evolving information on the latest technology and regulations concerning high-quality pharmaceutical production.
PDA is the recognized authoritative voice and leading technical organization in the field of parenteral science and technology. Through the development of Technical Reports and other documents and responses to regulatory initiatives, PDA and its members influence the future course of pharmaceutical products technology.
With more than 10,500 individual members worldwide, PDA draws its strength from the technical expertise of its membership. Conferences, meetings, and courses bring together pharmaceutical manufacturers, suppliers, users, academics, and regulatory officials to discuss and boost issues of mutual interest. These exchanges of technical knowledge, expertise, and best practices assist the advancement of pharmaceutical science and technology in the interest of public health.
More on PDA’s History - PDA History Book
The History of PDA: 65 Years of Connecting People, Science and Regulation.
This 232-page book details the explosive growth in PDA activities in the 15 years since the Golden Anniversary. Chapters cover the people who make PDA what it is, the scientific activities of the organization, the membership's influence on regulation, PDA’s manufacturing training facility, international growth, and conferences. Nearly 200 photos and graphics are included. Two 50th Anniversary booklets produced in 1996 are included as appendices.
View PDA History Book
To maximize product quality, availability, and value by connecting people, science, and regulation within the pharmaceutical and biopharmaceutical community so that PDA is:
To advance pharmaceutical/biopharmaceutical manufacturing science and regulation so members can better serve patients.